183 related articles for article (PubMed ID: 26998831)
21. Elevated SOX11 mRNA level correlates with favorable prognosis in mantle cell lymphoma.
He J; Xi Y; Gao N; Xu E; Xie L; Chang J; Liu J
J BUON; 2019; 24(4):1679-1685. PubMed ID: 31646825
[TBL] [Abstract][Full Text] [Related]
22. Leukemic Variant of Mantle Cell Lymphoma: Clinical Presentation and Management.
Isaac KM; Portell CA; Williams ME
Curr Oncol Rep; 2021 Jul; 23(9):102. PubMed ID: 34269910
[TBL] [Abstract][Full Text] [Related]
23. A highly sensitive and specific qPCR assay for quantification of the biomarker SOX11 in mantle cell lymphoma.
Hamborg KH; Bentzen HH; Grubach L; Hokland P; Nyvold CG
Eur J Haematol; 2012 Nov; 89(5):385-94. PubMed ID: 22827557
[TBL] [Abstract][Full Text] [Related]
24. Nuclear expression of the non B-cell lineage Sox11 transcription factor identifies mantle cell lymphoma.
Ek S; Dictor M; Jerkeman M; Jirström K; Borrebaeck CA
Blood; 2008 Jan; 111(2):800-5. PubMed ID: 17934069
[TBL] [Abstract][Full Text] [Related]
25. Flow cytometric analysis of SOX11: a new diagnostic method for distinguishing B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma from mantle cell lymphoma.
Wasik AM; Priebe V; Lord M; Jeppsson-Ahlberg Å; Christensson B; Sander B
Leuk Lymphoma; 2015 May; 56(5):1425-31. PubMed ID: 25120048
[TBL] [Abstract][Full Text] [Related]
26. SOX11 promotes tumor angiogenesis through transcriptional regulation of PDGFA in mantle cell lymphoma.
Palomero J; Vegliante MC; Rodríguez ML; Eguileor A; Castellano G; Planas-Rigol E; Jares P; Ribera-Cortada I; Cid MC; Campo E; Amador V
Blood; 2014 Oct; 124(14):2235-47. PubMed ID: 25092176
[TBL] [Abstract][Full Text] [Related]
27. Regulation of SOX11 expression through CCND1 and STAT3 in mantle cell lymphoma.
Mohanty A; Sandoval N; Phan A; Nguyen TV; Chen RW; Budde E; Mei M; Popplewell L; Pham LV; Kwak LW; Weisenburger DD; Rosen ST; Chan WC; Müschen M; Ngo VN
Blood; 2019 Jan; 133(4):306-318. PubMed ID: 30530749
[TBL] [Abstract][Full Text] [Related]
28. Knock-down of SOX11 induces autotaxin-dependent increase in proliferation in vitro and more aggressive tumors in vivo.
Conrotto P; Andréasson U; Kuci V; Borrebaeck CA; Ek S
Mol Oncol; 2011 Dec; 5(6):527-37. PubMed ID: 21880559
[TBL] [Abstract][Full Text] [Related]
29. SOX11 promotes tumor protective microenvironment interactions through CXCR4 and FAK regulation in mantle cell lymphoma.
Balsas P; Palomero J; Eguileor Á; Rodríguez ML; Vegliante MC; Planas-Rigol E; Sureda-Gómez M; Cid MC; Campo E; Amador V
Blood; 2017 Jul; 130(4):501-513. PubMed ID: 28533307
[TBL] [Abstract][Full Text] [Related]
30. SOX11/PRDX2 axis modulates redox homeostasis and chemoresistance in aggressive mantle cell lymphoma.
De Bolòs A; Sureda-Gómez M; Carreras-Caballé M; Rodríguez ML; Clot G; Beà S; Giné E; Campo E; Balsas P; Amador V
Sci Rep; 2024 Apr; 14(1):7863. PubMed ID: 38570586
[TBL] [Abstract][Full Text] [Related]
31. [Prognostic significance of miRNA-223 targeting SOX11 in mantle cell lymphoma].
Zhang Q; Zhang WT; Wu SS; Yuan JJ; Tian L; Liu YY; Zuo WL; Song YP; Zhou KS
Zhonghua Xue Ye Xue Za Zhi; 2018 Jul; 39(7):579-583. PubMed ID: 30122018
[No Abstract] [Full Text] [Related]
32. Prognostic significance of p53, Sox11, and Pax5 co-expression in mantle cell lymphoma.
Jing C; Zheng Y; Feng Y; Cao X; Xu C
Sci Rep; 2021 Jun; 11(1):11896. PubMed ID: 34099776
[TBL] [Abstract][Full Text] [Related]
33. Prognostic significance of microRNA 17-92 cluster expression in Egyptian chronic lymphocytic leukemia patients.
Khalifa MM; Zaki NE; Nazier AA; Moussa MA; Haleem RA; Rabie MA; Mansour AR
J Egypt Natl Canc Inst; 2021 Dec; 33(1):37. PubMed ID: 34866170
[TBL] [Abstract][Full Text] [Related]
34. Identification of CD5/Cyclin D1 Double-negative Pleomorphic Mantle Cell Lymphoma: A Clinicopathologic, Genetic, and Gene Expression Study.
Chuang WY; Chang ST; Yuan CT; Chang GJ; Chang H; Yeh CJ; Ueng SH; Kao HW; Wang TH; Wan YL; Shih LY; Chuang SS; Hsueh C
Am J Surg Pathol; 2020 Feb; 44(2):232-240. PubMed ID: 31688139
[TBL] [Abstract][Full Text] [Related]
35. SOX11 as a minimal residual disease marker for Mantle cell lymphoma.
Simonsen AT; Sørensen CD; Ebbesen LH; Bødker JS; Bentzen HH; Nyvold CG
Leuk Res; 2014 Aug; 38(8):918-24. PubMed ID: 24878000
[TBL] [Abstract][Full Text] [Related]
36. MicroRNA signature obtained from the comparison of aggressive with indolent non-Hodgkin lymphomas: potential prognostic value in mantle-cell lymphoma.
Goswami RS; Atenafu EG; Xuan Y; Waldron L; Reis PP; Sun T; Datti A; Xu W; Kuruvilla J; Good DJ; Lai R; Church AJ; Lam WS; Baetz T; Lebrun DP; Sehn LH; Farinha P; Jurisica I; Bailey DJ; Gascoyne RD; Crump M; Kamel-Reid S
J Clin Oncol; 2013 Aug; 31(23):2903-11. PubMed ID: 23835716
[TBL] [Abstract][Full Text] [Related]
37. SOX11 defines two different subtypes of mantle cell lymphoma through transcriptional regulation of BCL6.
Palomero J; Vegliante MC; Eguileor A; Rodríguez ML; Balsas P; Martínez D; Campo E; Amador V
Leukemia; 2016 Jul; 30(7):1596-9. PubMed ID: 26710884
[No Abstract] [Full Text] [Related]
38. SOX11 augments BCR signaling to drive MCL-like tumor development.
Kuo PY; Jatiani SS; Rahman AH; Edwards D; Jiang Z; Ahr K; Perumal D; Leshchenko VV; Brody J; Shaknovich R; Ye BH; Parekh S
Blood; 2018 May; 131(20):2247-2255. PubMed ID: 29615403
[TBL] [Abstract][Full Text] [Related]
39. SOX11 regulates the pro-apoptosis signal pathway and predicts a favorable prognosis of mantle cell lymphoma.
Yang W; Wang Y; Yu Z; Li Z; An G; Liu W; Lv R; Ma L; Yi S; Qiu L
Int J Hematol; 2017 Aug; 106(2):212-220. PubMed ID: 28429312
[TBL] [Abstract][Full Text] [Related]
40. Aggressive Cyclin D1 Negative Blastoid Variant Mantle Cell Lymphoma-A Case Report.
Loungani L; Mundhe R; Chinoy R
Int J Surg Pathol; 2022 Apr; 30(2):190-194. PubMed ID: 34180720
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]